These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 7271267)
1. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics]. Shneĭder MA; Shtil'bans EB; Paleĭ EI; Vil'ner LM; Tereshin IM Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267 [TBL] [Abstract][Full Text] [Related]
2. [Effect of polyene antibiotics on the increase in specific resistance due to inactivated antiviral vaccines]. Vil'ner LM; Ral'f NM; Finogenova EV; Shneĭder MA; Tereshin IM Antibiotiki; 1980 Sep; 25(9):669-73. PubMed ID: 7416734 [TBL] [Abstract][Full Text] [Related]
3. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation]. Polianskaia NIu Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532 [No Abstract] [Full Text] [Related]
4. Development and characterization of a live attenuated influenza B virus vaccine candidate. Seo SU; Byun YH; Lee EY; Jung EJ; Jang YH; Kim HA; Ha SH; Lee KH; Seong BL Vaccine; 2008 Feb; 26(7):874-81. PubMed ID: 18207290 [TBL] [Abstract][Full Text] [Related]
5. [Live influenza vaccine]. Smorodintsev AA Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315 [No Abstract] [Full Text] [Related]
6. [Possibility of preparing inactivated influenza vaccine by a combination of gel chromatography and ultrafiltration]. Fridman AL; Ermolaev AI; Bichurina MA; Polianskaia NIu; Zheleznova NV Tr Inst Im Pastera; 1979; 52():103-7. PubMed ID: 550531 [No Abstract] [Full Text] [Related]
7. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
8. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041 [TBL] [Abstract][Full Text] [Related]
9. [Obtaining a lyophilized preparation of inactivated influenza vaccine]. Goriunova VV; Bichurina MA; Gerasimov VA Tr Inst Im Pastera; 1979; 52():110-4. PubMed ID: 550533 [No Abstract] [Full Text] [Related]
10. Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system. Brett IC; Johansson BE Virology; 2005 Sep; 339(2):273-80. PubMed ID: 15996702 [TBL] [Abstract][Full Text] [Related]
11. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208 [TBL] [Abstract][Full Text] [Related]
12. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant. Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689 [TBL] [Abstract][Full Text] [Related]